EMA Set To Discuss Safety Of Ranitidine Drugs Soon

 
• By Vibha Sharma

Following the announcement in the US that ranitidine drugs must be withdrawn from the market, the European Medicines Agency told the Pink Sheet it would decide on the fate of these medicines in the EU after wrapping up its own inquiry.

Nitrosodimethylamine
EMA Is Investing The Safety Of Ranitidine Medicines • Source: Shutterstock

More from Manufacturing

More from Compliance